AN2 Therapeutics Announces Extension of Funding for Tuberculosis Research Collaboration with GSK

Business Wire•28/09/2026•07:00 ET

Funding from Gates Foundation supports continued advancement of boron-based LeuRS inhibitors for the treatment of tuberculosis

Get started

Create a free account to read the full story and Whiz Insights.

Already have an account? Log in